0000890465-13-000037.txt : 20131226 0000890465-13-000037.hdr.sgml : 20131225 20131226173605 ACCESSION NUMBER: 0000890465-13-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131223 FILED AS OF DATE: 20131226 DATE AS OF CHANGE: 20131226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRONINGER JAMES G CENTRAL INDEX KEY: 0001013420 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 131299185 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-12-23 0000890465 NPS PHARMACEUTICALS INC NPSP 0001013420 GRONINGER JAMES G 550 HILLS DRIVE BEDMINSTER NJ 07921 1 0 0 0 Common Stock 2013-12-23 4 M 0 3000 21.73 A 3750 D Common Stock 2013-12-23 4 S 0 3000 29.50 D 750 D Stock Options 21.73 2013-12-23 4 M 0 3000 0 D 2014-05-20 Common Stock 3000 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 10, 2013 On May 20, 2004, the Reporting Person received a grant of 3,000 stock options under the Issuer's 1998 Stock Option Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 2% each month thereafter. As of the date of this filing, 3,000 stock options have vested. /s/James Groninger, by Edward Stratemeier as attorney-in-fact 2013-12-26